U.S. Entertainment Stock News

In early February 2026, Graphic Packaging Holding reported weaker guidance, including an expected decline in 2026 Adjusted EBITDA, and soon after became the subject of a Pomerantz LLP investigation into potential securities law violations. These developments coincided with Atlantic Investment Management exiting its position, flat unit sales, earnings pressure, and David Einhorn significantly expanding his stake in the company. Together, the softer outlook, legal scrutiny, and contrasting...

Recent performance snapshot Upbound Group (UPBD) has caught investor attention after recent share price moves, with the stock last closing at US$22.78 and showing mixed return patterns over the past year and beyond. See our latest analysis for Upbound Group. The recent 12.2% 7 day and 18.1% 30 day share price returns suggest short term momentum is building, even though the 1 year total shareholder return of 7.6% points to a weaker longer term picture. If this move has you thinking about what...

If you are looking at Sonoco Products and wondering whether the current share price offers good value, this article will walk through what the numbers are really saying about the stock. The shares most recently closed at US$56.45, with returns of 9.3% over 7 days, 16.2% over 30 days, 27.2% year to date, 26.4% over 1 year, 7.2% over 3 years and 12.8% over 5 years. This helps frame how the market has been reassessing the company over different time frames. Recent coverage of Sonoco Products...

If you are wondering whether Dynex Capital's current share price offers good value, you are not alone, especially with income focused investors often watching mortgage REITs closely. The stock last closed at US$14.13, with returns of 0.6% over 7 days, a 3.4% decline over 30 days, 0.4% year to date, 17.4% over 1 year, 59.2% over 3 years and 35.7% over 5 years. This raises fair questions about how that performance lines up with the underlying value. Recent coverage around Dynex Capital has...

Why GATX’s latest earnings and capital moves matter for shareholders GATX (GATX) just posted double digit earnings growth for 2025, completed its large Wells Fargo railcar acquisition, and paired those results with higher dividends and a fresh $300 million buyback authorization. See our latest analysis for GATX. The recent rally has been strong, with a 1 day share price return of 5.0% and a 90 day share price return of 24.53% lifting GATX to US$198.52. The 5 year total shareholder return of...

In recent days, ACADIA Pharmaceuticals drew fresh attention after Wall Street analysts reacted to updates on its neurology and rare‑disease pipeline, highlighting the company’s transition from a single‑product focus to a broader portfolio with additional development‑stage and deal‑driven assets. This shift toward a more diversified set of neurology and genetic disorder programs has become a key talking point among analysts assessing how ACADIA balances Nuplazid’s importance with new...

If you are looking at Cytokinetics and wondering whether the current share price actually reflects its underlying value, you are not alone. The stock most recently closed at US$67.94, with returns of 2.5% over 7 days, 7.1% over 30 days, 10.1% year to date and 41.1% over the past year, which naturally raises questions about what is already priced in and what is not. Recent attention around Cytokinetics has focused on its pipeline progress and regulatory milestones, which often influence how...

Wondering whether Trane Technologies at around US$467 a share lines up with its underlying value, or if expectations have already run ahead of the story. The stock has posted returns of 0.4% over the last 7 days, 20.9% over the last 30 days, 17.4% year to date, 36.0% over 1 year and 214.8% over 5 years, which naturally raises questions about how much future upside or downside is now priced in. Recent news flow around Trane has highlighted ongoing attention on building efficiency and climate...

In February 2026, Trex Company expanded its Performance-Engineered outdoor living portfolio with cooler-running SunCom comfortable decking, new Transcend Lineage 1"x4" boards, enhanced railing options, and composite fencing, while appointing industry veteran Irene Tasi to its Board and Audit and Compensation Committees. Alongside these product launches and governance changes, Trex’s recent industry awards and sustainability rankings highlight a brand pushing innovation even as competitive...

Savara Inc. recently announced that the FDA has accepted for review its Biologics License Application for MOLBREEVI to treat autoimmune pulmonary alveolar proteinosis, granting Priority Review with a PDUFA action date of August 22, 2026. This filing caps a series of expedited and rare-disease designations across the US, EU and UK, underscoring MOLBREEVI’s potential importance for a severely underserved patient population. We’ll now examine how FDA Priority Review for MOLBREEVI, alongside its...

Mattel (MAT) has given investors a lot to digest in February, pairing a new US$1.5b share repurchase authorization with detailed 2026 product reveals and fresh earnings and sales guidance. See our latest analysis for Mattel. Despite the new product slate and the US$1.5b buyback authorization, Mattel’s recent share price return has been weak, with a 30 day share price return of 15.77% and a 1 year total shareholder return of 17.84%. This suggests momentum has been fading even as management...

ORIC Pharmaceuticals (NasdaqGS:ORIC) reports progress in its cancer therapy pipeline, with lead drug candidates entering Phase 1b clinical trials. The company announces new collaborations with Pfizer, Bayer, and Johnson & Johnson, aimed at advancing therapies that target resistance mechanisms in cancer treatment. These developments are drawing increased investor attention as they represent material steps in ORIC Pharmaceuticals' clinical and partnership strategy. ORIC Pharmaceuticals...

Rosen Law Firm announced that the U.S. District Court for the Southern District of New York has certified a class action and is reviewing a proposed US$740,000,000 settlement to resolve claims by DiDi Global ADS purchasers, with a hearing scheduled for June 16, 2026. If approved, this sizable settlement would cap a major legal overhang for DiDi Global, clarifying potential liabilities and closing a lengthy litigation chapter. Next, we will examine how this proposed US$740,000,000 class...

What Restaurant Brands International’s Recent Trading Tells You Restaurant Brands International (QSR) has drawn investor interest after a modest 0.3% gain in the latest session, adding to a 4.1% move over the past week and contrasting with a slight past 3 months pullback. See our latest analysis for Restaurant Brands International. At a share price of $68.82, Restaurant Brands International’s recent 7 day share price return of 4.05% sits against a quieter year to date move. However, a 1 year...

Equifax (EFX) has drawn fresh attention after launching Optimal Path, an AI driven credit score planner offered free inside the myEquifax mobile app, putting its data and analytics capabilities directly in front of U.S. consumers. See our latest analysis for Equifax. Equifax shares trade at US$197.46, with a 1 day share price return of 1.11% and a 7 day return of 2.42%. However, a 1 year total shareholder return decline of 16.52% suggests recent momentum has faded despite product launches...

Star Bulk Carriers recently traded higher, ahead of its 25 February 2026 earnings release, with projections pointing to strong year-over-year earnings growth and analyst estimates largely unchanged, reflected in its current Zacks Rank of #3 (Hold). Investor attention has increased as the company’s forward P/E sits below the industry average, suggesting a relatively lower valuation alongside expectations for robust upcoming results. Next, we’ll examine how anticipation of stronger earnings...

Medpace Holdings (MEDP) recently reported quarterly results that came in ahead of market expectations and issued 2026 guidance, but a softer book to bill ratio and a new securities law investigation have complicated the story. See our latest analysis for Medpace Holdings. The share price has been under pressure recently, with a 30 day share price return of 22.83% and a 90 day share price return of 26.63%. However, the 1 year total shareholder return of 33.38% and 3 year total shareholder...

Smithfield Foods (SFD) is back on investors’ radar after recent share price moves, with the stock showing mixed short term returns but stronger performance over the past month and the past three months. See our latest analysis for Smithfield Foods. The latest share price of US$25.04 sits alongside a 30 day share price return of 10.07% and a 90 day share price return of 18.50%. The 1 year total shareholder return of 24.16% points to momentum that has been building rather than fading. If recent...

If you are wondering whether ASML Holding’s share price still makes sense after a strong run, or if expectations have gone too far, this article will walk you through what the current market price might be implying. With the stock last closing at US$1,469.59 and returns of 4.5% over 7 days, 5.8% over 30 days, 26.3% year to date and 100.8% over 1 year, many investors are asking what is already priced in. Recent coverage has focused on ASML’s central role in supplying advanced semiconductor...

In February 2026, Howmet Aerospace completed several fixed‑rate senior unsecured note offerings totaling about US$1.20 billion, with maturities ranging from 2028 to 2036, to help finance its approximately US$1.80 billion proposed acquisition of Consolidated Aerospace Manufacturing and supplement borrowings under its commercial paper program and existing cash. This combination of debt‑funded acquisition plans, ongoing share repurchases, and solid 2025 earnings puts Howmet’s balance sheet,...

Axon Enterprise stock snapshot Axon Enterprise (AXON) has attracted attention after a sharp pullback, with the share price down about 29% over the past month and 18% over the past 3 months, despite positive annual revenue and net income growth. See our latest analysis for Axon Enterprise. The recent 29.2% one-month share price decline and 23.0% year-to-date share price return have cooled momentum, even though the three-year total shareholder return of 122.6% and five-year total shareholder...

Dollar General (NYSE:DG) has launched a new Dollar General Market format featuring an expanded grocery assortment. The remodel brings more fresh produce, meat, and everyday food essentials to communities with limited grocery options. The change reflects the company’s focus on community investment and access to food in underserved areas. For you as an investor, this move sits at the intersection of discount retail and everyday essentials, an area where consistent foot traffic can matter as...

Why Goodyear’s latest earnings matter for shareholders Goodyear Tire & Rubber (GT) just reported fourth quarter and full year 2025 results, with stronger quarterly profit but a full year net loss, giving investors mixed signals on the stock’s recent performance. See our latest analysis for Goodyear Tire & Rubber. The mixed earnings story is also showing up in the trading data, with the 90 day share price return of 9.83% pointing to improving momentum. In contrast, the 1 year total shareholder...

Verra Mobility (VRRM) drew fresh investor attention after securing a 10 year contract worth roughly US$160 million with Hawaii’s Department of Transportation to expand its automated red light and speed enforcement program statewide. See our latest analysis for Verra Mobility. The Hawaii contract follows another large win with New York City earlier in February. Together, these updates contrast with a softer share price picture, with a 30-day share price return of an 11.16% decline, a...